The University of Chicago Header Logo

David L. Grinblatt

InstitutionUniversity of Chicago
AddressChicago IL 60637
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    U10CA035199     (GRINBLATT, DAVID L)Sep 1, 1983 - May 31, 2015
    Community Clinical Oncology Program
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mohammadi-Oroujeh M, Mehreen A, Grinblatt DL. Epstein-Barr Virus Driven Hodgkin's Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma. Case Rep Hematol. 2023; 2023:6669174. PMID: 38146540; PMCID: PMC10749716.
    2. Flick ED, Terebelo HR, Fish S, Kitali A, Mahajan V, Nifenecker M, Sullivan K, Thaler P, Ussery S, Grinblatt DL. The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research. Oncologist. 2023 08 03; 28(8):657-663. PMID: 37285045; PMCID: PMC10400140.
      Citations:    Fields:    Translation:Humans
    3. Patel JL, Erba HP, Savona MR, Grinblatt DL, Clark M, Clive TC, Smart TB, Makinde AY, DeGutis IS, Yu E, Eggington JM, George TI. Genomic Data Heterogeneity across Molecular Diagnostic Laboratories: A Real-World Connect Myeloid Disease Registry Perspective on Variabilities in Genomic Assay Methodology and Reporting. J Mol Diagn. 2023 08; 25(8):611-618. PMID: 37517825.
      Citations:    Fields:    Translation:Humans
    4. Tomlinson B, de Lima M, Thompson MA, Pollyea DA, Savona MR, Sekeres MA, Kurtin SE, Maciejewski JP, Revicki DA, Flick ED, Kiselev P, DeGutis IS, Nifenecker M, Steensma DP, Scott BL, Cogle CR, Grinblatt DL, Komrokji RS, Roboz GJ, Abedi M, Garcia-Manero G, Patel JL, George TI, Louis CU, Erba HP. Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care. Transplant Cell Ther. 2023 07; 29(7):460.e1-460.e9. PMID: 37086851.
      Citations:    Fields:    Translation:Humans
    5. Derman BA, Kansagra A, Zonder J, Stefka AT, Grinblatt DL, Anderson LD, Gurbuxani S, Narula S, Rayani S, Major A, Kin A, Jiang K, Karrison T, Jasielec J, Jakubowiak AJ. Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study. JAMA Oncol. 2022 09 01; 8(9):1278-1286. PMID: 35862034; PMCID: PMC9305600.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    6. Strohbehn GW, Saint S, Grinblatt DL, Moe J, Dhaliwal G. As the Story Unfolds. J Hosp Med. 2021 07; 16(7):428-433. PMID: 34197309.
      Citations:    Fields:    
    7. Sullivan K, Kaminer LS, Grinblatt DL, Campbell NP, Nocon CC, Harper AJ, Kang JH, Sarav M, Curtis BR, Brockstein BE. Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet Antibodies. JCO Oncol Pract. 2021 03; 17(3):153-155. PMID: 33270522.
      Citations:    Fields:    Translation:Humans
    8. Patel JL, Abedi M, Cogle CR, Erba HP, Foucar K, Garcia-Manero G, Grinblatt DL, Komrokji RS, Kurtin SE, Maciejewski JP, Pollyea DA, Revicki DA, Roboz GJ, Savona MR, Scott BL, Sekeres MA, Steensma DP, Thompson MA, Dawn Flick E, Kiselev P, Louis CU, Nifenecker M, Swern AS, George TI. Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes. Int J Lab Hematol. 2021 Jun; 43(3):426-432. PMID: 33220019; PMCID: PMC8247031.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    9. Sharman JP, Cocks K, Nabhan C, Lamanna N, Kay NE, Grinblatt DL, Flowers CR, Davids MS, Kiselev P, Swern AS, Sullivan K, Gharibo MM, Flick ED, Trigg A, Mato A. Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry. EJHaem. 2020 Jul; 1(1):188-198. PMID: 35847738; PMCID: PMC9176138.
      Citations: 1     
    10. Pollyea DA, George TI, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, Grinblatt DL, Komrokji RS, Maciejewski JP, Revicki DA, Roboz GJ, Savona MR, Scott BL, Sekeres MA, Thompson MA, Kurtin SE, Louis CU, Nifenecker M, Flick ED, Swern AS, Kiselev P, Steensma DP, Erba HP. Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry. EJHaem. 2020 Jul; 1(1):58-68. PMID: 35847712; PMCID: PMC9176048.
      Citations: 4     
    11. Mato A, Nabhan C, Lamanna N, Kay NE, Grinblatt DL, Flowers CR, Farber CM, Davids MS, Swern AS, Sullivan K, Flick ED, Gressett Ussery SM, Gharibo M, Kiselev P, Sharman JP. The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites. Blood Adv. 2020 04 14; 4(7):1407-1418. PMID: 32271900; PMCID: PMC7160291.
      Citations: 8     Fields:    Translation:Humans
    12. Belopolsky Y, Grinblatt DL, Dunnenberger HM, Sabatini LM, Joseph NE, Fimmel CJ. A Case of Severe, Nilotinib-Induced Liver Injury. ACG Case Rep J. 2019 Feb; 6(2):e00003. PMID: 31616712; PMCID: PMC6657995.
      Citations: 5     
    13. Mato A, Nabhan C, Kay NE, Lamanna N, Kipps TJ, Grinblatt DL, Flowers CR, Farber CM, Davids MS, Kiselev P, Swern AS, Bhushan S, Sullivan K, Flick ED, Sharman JP. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry. Clin Lymphoma Myeloma Leuk. 2018 02; 18(2):114-124.e2. PMID: 29352719.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    14. Ahn IE, Farber CM, Davids MS, Grinblatt DL, Kay NE, Lamanna N, Mato A, Nabhan C, Kiselev P, Swern AS, Flick ED, Sullivan K, Sharman JP, Flowers CR. Early progression of disease as a predictor of survival in chronic lymphocytic leukemia. Blood Adv. 2017 Nov 28; 1(25):2433-2443. PMID: 29296893; PMCID: PMC5729627.
      Citations: 5     Fields:    
    15. Komrokji R, Swern AS, Grinblatt D, Lyons RM, Tobiasson M, Silverman LR, Sayar H, Vij R, Fliss A, Tu N, Sugrue MM. Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies. Oncologist. 2018 02; 23(2):159-170. PMID: 29118268; PMCID: PMC5813747.
      Citations: 12     Fields:    Translation:Humans
    16. Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP. Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States. BMC Cancer. 2017 03 16; 17(1):198. PMID: 28302090; PMCID: PMC5356242.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    17. Mato A, Nabhan C, Kay NE, Weiss MA, Lamanna N, Kipps TJ, Grinblatt DL, Flinn IW, Flowers CR, Farber CM, Kiselev P, Swern AS, Sullivan K, Flick ED, Sharman JP, Kozloff MF. Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres. Br J Haematol. 2016 Dec; 175(5):892-903. PMID: 27861736; PMCID: PMC5132115.
      Citations: 23     Fields:    Translation:Humans
    18. Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. BMC Cancer. 2016 08 19; 16:652. PMID: 27538433; PMCID: PMC4991094.
      Citations: 6     Fields:    Translation:Humans
    19. Grinblatt DL, Sekeres MA, Komrokji RS, Swern AS, Sullivan KA, Narang M. Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA registry. Leuk Lymphoma. 2015 Apr; 56(4):887-95. PMID: 24956145.
      Citations: 16     Fields:    Translation:Humans
    20. Pashos CL, Flowers CR, Kay NE, Weiss M, Lamanna N, Farber C, Lerner S, Sharman J, Grinblatt D, Flinn IW, Kozloff M, Swern AS, Street TK, Sullivan KA, Harding G, Khan ZM. Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Support Care Cancer. 2013 Oct; 21(10):2853-60. PMID: 23748484.
      Citations: 17     Fields:    Translation:Humans
    21. Kline J, Grinblatt D, Zimmerman T, Conner K, Muhs C, Gajewski T, Van Besien K, Smith SM, Poiré X. Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leuk Lymphoma. 2010 Jul; 51(7):1241-50. PMID: 20496994.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    22. Mehta J, Mehta J, Frankfurt O, Altman J, Evens A, Tallman M, Gordon L, Williams S, Winter J, Krishnamurthy J, Duffey S, Singh V, Meagher R, Grinblatt D, Kaminer L, Singhal S. Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2009 Sep; 50(9):1434-41. PMID: 19603344.
      Citations: 15     Fields:    Translation:HumansCells
    23. Grinblatt DL, Yu D, Hars V, Vardiman JW, Powell BL, Nattam S, Silverman LR, de Castro C, Stone RM, Bloomfield CD, Larson RA, Cancer and Leukemia Group. Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93. PMID: 19025972; PMCID: PMC2887616.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    24. Lal A, Brockstein B, Grinblatt D. Review: coagulopathy and factor inhibitors. Clin Adv Hematol Oncol. 2008 Dec; 6(12):925-7. PMID: 19209143.
      Citations:    Fields:    Translation:Humans
    25. Smith SM, Grinblatt D, Johnson JL, Niedzwiecki D, Rizzieri D, Bartlett NL, Cheson BD, Cancer and Leukemia Group B. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol. 2008 Feb; 140(3):313-9. PMID: 18217897.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    26. Mehta J, Gordon LI, Tallman MS, Winter JN, Evens AM, Evens AO, Frankfurt O, Williams SF, Grinblatt D, Kaminer L, Meagher R, Singhal S. Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially? Bone Marrow Transplant. 2006 Jul; 38(2):95-100. PMID: 16751789.
      Citations: 24     Fields:    Translation:Humans
    27. Singhal S, Gordon LI, Tallman MS, Winter JN, Evens AM, Evens AO, Frankfurt O, Williams SF, Grinblatt D, Kaminer L, Meagher R, Mehta J. Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006 Mar; 37(6):553-7. PMID: 16444282.
      Citations: 4     Fields:    Translation:Humans
    28. Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura. Pediatr Neurol. 2006 Jan; 34(1):60-2. PMID: 16376282.
      Citations: 1     Fields:    Translation:Humans
    29. Klein CE, Kastrissios H, Miller AA, Hollis D, Yu D, Rosner GL, Grinblatt DL, Larson RA, Ratain MJ. Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study. Cancer Chemother Pharmacol. 2006 Jan; 57(2):199-206. PMID: 16158312.
      Citations: 5     Fields:    Translation:Humans
    30. Smith SM, Grinblatt D, van Besien K, Smith SM, Grinblatt D, van Besien K. Autologous and allogeneic transplantation for aggressive NHL. Cytotherapy. 2002; 4(3):223-40. PMID: 12194719.
      Citations: 4     Fields:    Translation:Humans
    31. Laport GG, Fleming GF, Waggoner S, Zimmerman TM, Grinblatt DL, Williams SF. A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer. Bone Marrow Transplant. 2001 Apr; 27(7):677-81. PMID: 11360105.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    32. Laport GG, Valone FH, Zimmerman TM, Grinblatt DL, Van Vlasselaer P, Still BJ, Williams SF. Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancer. Cytotherapy. 2000; 2(3):179-85. PMID: 12042040.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    33. Zimmerman TM, Michelson GC, Mick R, Grinblatt DL, Williams SF. Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma. J Clin Apher. 1999; 14(1):31-4. PMID: 10355661.
      Citations: 1     Fields:    Translation:HumansCells
    34. Zimmerman TM, Grinblatt DL, Malloy R, Williams SF. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma. Cancer. 1998 Oct 15; 83(8):1540-5. PMID: 9781947.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    35. Laport GF, Grad G, Grinblatt DL, Bitran JD, Williams SF. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience. Bone Marrow Transplant. 1998 Jan; 21(2):127-32. PMID: 9489628.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    36. Lazarus HM, Winton EF, Williams SF, Grinblatt D, Campion M, Cooper BW, Gunn H, Manfreda S, Isaacs RE. Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant. 1995 Jun; 15(6):935-42. PMID: 7581094.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    37. Kies MS, Grinblatt D, Runge-Morris M, Blough R, Watkins A, Taylor S. Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck. Invest New Drugs. 1994; 12(1):45-7. PMID: 7960605.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    38. Grinblatt DL, Benson AB. Response of pancreatic carcinoma to 5-fluorouracil and leucovorin. Am J Med. 1992 Jan; 92(1):107-9. PMID: 1731500.
      Citations: 1     Fields:    Translation:Humans
    39. Hoppel CL, Grinblatt D, Kwok HC, Arora PK, Singh MP, Sayre LM, Greenblatt D. Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP. Biochem Biophys Res Commun. 1987 Oct 29; 148(2):684-93. PMID: 3500717.
      Citations: 13     Fields:    Translation:AnimalsCells
    Grinblatt's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (184)
    Co-Authors (17)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors